Prognostic significance of intra-aortic balloon pumping support in patients with acute myocardial infarction and veno-arterial extracorporeal membrane oxygenation therapy.
暂无分享,去创建一个
I. Komuro | M. Hori | Hiroshi Sato | H. Mizuno | S. Hikoso | Y. Sakata | Y. Sakata | T. Kitamura | D. Nakatani | S. Suna | S. Komukai | T. Dohi | T. Kojima | H. Kida | A. Sunaga | Y. Sotomi | Katsuki Okada | B. Oeun | Taiki Sato | Shinichiro Suna | Takayuki Kojima
[1] A. Hirayama,et al. Unmet needs for emergency care and prevention of prehospital death in acute myocardial infarction. , 2020, Journal of cardiology.
[2] V. Figueredo,et al. Mechanical Circulatory Support in Women. , 2020, Journal of cardiology.
[3] Zhen Xing,et al. Short-term outcomes of intra-aortic balloon pump combined with venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis. , 2019, Artificial organs.
[4] B. Gersh,et al. Concomitant Intra-Aortic Balloon Pump Use in Cardiogenic Shock Requiring Veno-Arterial Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis , 2018, Circulation. Cardiovascular interventions.
[5] P. Leprince,et al. Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[6] James E. Tcheng,et al. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials , 2018, Circulation.
[7] P. Demondion,et al. Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation , 2018, European heart journal. Acute cardiovascular care.
[8] H. Yasunaga,et al. The Effect of Intraaortic Balloon Pumping Under Venoarterial Extracorporeal Membrane Oxygenation on Mortality of Cardiogenic Patients: An Analysis Using a Nationwide Inpatient Database , 2016, Critical care medicine.
[9] N. Chou,et al. Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation , 2016, Scientific Reports.
[10] J. Goldstein,et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation o , 2015, Journal of the American College of Cardiology.
[11] D. Kolte,et al. Peripheral Venoarterial Extracorporeal Membrane Oxygenation in Combination with Intra-Aortic Balloon Counterpulsation in Patients with Cardiovascular Compromise , 2014, Cardiology.
[12] P. Leprince,et al. Intra-Aortic Balloon Pump Effects on Macrocirculation and Microcirculation in Cardiogenic Shock Patients Supported by Venoarterial Extracorporeal Membrane Oxygenation* , 2014, Critical care medicine.
[13] D. Brodie,et al. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. , 2014, Journal of the American College of Cardiology.
[14] T. Park,et al. Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock , 2014, BMC Anesthesiology.
[15] Xiaojing Ma,et al. Combining ECMO with IABP for the treatment of critically Ill adult heart failure patients. , 2014, Heart, lung & circulation.
[16] K. Soma,et al. Therapeutic strategy using extracorporeal life support, including appropriate indication, management, limitation and timing of switch to ventricular assist device in patients with acute myocardial infarction , 2014, Journal of Artificial Organs.
[17] Yeong-Hoon Choi,et al. Outcomes after peripheral extracorporeal membrane oxygenation therapy for postcardiotomy cardiogenic shock: a single-center experience. , 2013, The Journal of surgical research.
[18] G. Schuler,et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.
[19] Kay-Hyun Park,et al. Results of Extracorporeal Membrane Oxygenation (ECMO) Support before Coronary Reperfusion in Cardiogenic Shock with Acute Myocardial Infarction , 2011, The Korean Journal of Thoracic and Cardiovascular Surgery.
[20] M. Hori,et al. Impact of diabetes mellitus on rehospitalization for heart failure among survivors of acute myocardial infarction in the percutaneous coronary intervention era. , 2009, Circulation journal : official journal of the Japanese Circulation Society.
[21] Pascal Leprince,et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock* , 2008, Critical care medicine.
[22] Peter C Austin,et al. The performance of different propensity score methods for estimating marginal hazard ratios , 2007, Statistics in medicine.
[23] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[24] Adelaide,et al. Bivalirudin for patients with acute coronary syndromes. , 2006, The New England journal of medicine.
[25] I. Komuro,et al. Incidence, predictors, and subsequent mortality risk of recurrent myocardial infarction in patients following discharge for acute myocardial infarction. , 2013, Circulation journal : official journal of the Japanese Circulation Society.
[26] I. Komuro,et al. Oral treatment with nicorandil at discharge is associated with reduced mortality after acute myocardial infarction. , 2012, Journal of cardiology.
[27] J. Maessen,et al. The acute effect of intra-aortic balloon counterpulsation during extracorporeal life support: an experimental study. , 2007, Artificial organs.
[28] B. Kiaii,et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. , 2004, The Annals of thoracic surgery.